Summary of the Medical Aesthetic Industry Conference Call Industry Overview - The medical aesthetic industry is experiencing intensified competition, with upstream companies facing profit erosion on single products and downstream chain medical aesthetic institutions accelerating mergers and acquisitions. Leading brands like Meili Tianyuan are emerging, indicating a shift from product-driven growth to user demand-driven growth, resulting in a transfer of power within the industry towards downstream players [1][2][16]. Key Points on Companies Juzhi Biotechnology - In the first half of 2025, Juzhi Biotechnology's sales were impacted by a public relations incident, with its brand Kefu Mei not recovering sales during the Double Eleven shopping festival. Contributing factors include underwhelming influencer marketing recovery and a 20% reduction in advertising budget. The GMV from Douyin channel dropped over 60% year-on-year, reflecting challenges in brand marketing strategies [1][4][3]. Jinbo Biotechnology - Jinbo Biotechnology's revenue and profit growth slowed in Q3 2025, primarily due to price erosion of its core product, the 4mg ultra-pure product, which saw its terminal price drop from a suggested retail price of 6,800 yuan to just over 1,000 yuan. The company is expanding its distribution channels to 4,000, which is lower than competitors like facial fillers. New product launches are facing high sales expense ratios, putting pressure on profits [1][5][8]. Meili Tianyuan - Meili Tianyuan has distinguished itself through excellent user operations, digital membership management, and effective acquisition strategies. The brand has maintained same-store growth of 5% to 6% over the past two years, with a 10% increase in user numbers offsetting a 5% decline in average transaction value. The company has expanded its scale through acquisitions, increasing its store count to around 700-800 [1][11][10]. Industry Dynamics - Downstream chain medical aesthetic institutions are enhancing their operational capabilities through mergers and acquisitions, which is increasing their bargaining power. Leading brands like Meili Tianyuan are establishing close ties with upstream companies through customized collaborations, achieving mutual growth [1][6][12]. Challenges and Opportunities - Upstream companies are facing increased competition and declining profits on single products, necessitating strategic adjustments to attract users. Downstream institutions are experiencing high customer acquisition costs and insufficient standardization of products, leading to increased survival pressure. However, those companies that can effectively manage user needs and supply chain advantages are likely to emerge successfully from the current challenges [1][9][16]. Conclusion - The medical aesthetic industry is transitioning from a phase of rapid growth to one characterized by demand stabilization and intensified competition. Downstream companies must adapt quickly to market changes, while upstream companies need to enhance their channel management capabilities. Despite the challenges, companies that excel in user demand understanding and membership operations are positioned to achieve new growth [1][16][15].

Group 1 - L'Oréal has dropped out of the top 10 beauty brands, with domestic brands gaining market share, particularly on platforms like Douyin, where domestic brands occupy 7 out of the top 10 spots [3][9] - The beauty market is experiencing a significant shift, with domestic brands like Han Shu and Proya leading, while international brands face pressure [3][9] - The cosmetic market is seeing a rise in niche segments, such as neck care, with brands like KAZOO and SDX emerging as notable players [3] Group 2 - The medical beauty market is projected to reach 370 billion by 2025, attracting beauty companies to diversify into this sector [4] - Companies like Juzhi Biotech have received NMPA approval for innovative collagen products, indicating increased competition in the collagen injection market [4] - Challenges in the medical beauty sector include high regulatory barriers and product homogenization, necessitating breakthroughs in technology for sustainable growth [4] Group 3 - The soap market is undergoing a transformation, with a shift towards high-end products priced between 10-20 yuan, driven by consumer demand for natural ingredients [5] - Handmade soaps are gaining popularity among environmentally conscious consumers, although they face challenges in scaling production [5] - Brands are innovating by expanding usage scenarios for soaps, indicating a trend towards personalized and situational products [5] Group 4 - PDRN technology is transitioning from a niche medical beauty ingredient to a mainstream skincare component, with innovations in raw materials and product formulations [6] - The market is seeing a diversification of PDRN applications, including anti-aging and sensitive skin care, enhancing its appeal [6] - Companies are leveraging AI and molecular optimization to improve product efficacy and absorption [6] Group 5 - Hong Kong is emerging as a testing ground for domestic beauty brands aiming for global expansion, with brands like Guansha and Dr. Wong adopting different strategies to penetrate the market [8] - The recovery of Hong Kong's tourism sector provides a significant opportunity for these brands to attract international customers [8] Group 6 - The luxury beauty sector is entering a "cooling period," with major players like Kering and L'Oréal focusing on resource sharing and strategic partnerships rather than aggressive expansion [10] - L'Oréal's acquisition of Kering's Creed brand for 4 billion euros highlights the trend of luxury brands consolidating their beauty portfolios [10] - The collaboration also signals a growing interest in health and longevity science within the beauty industry [10] Group 7 - The medical beauty industry is focusing on technological advancements, with new materials becoming a strategic priority [11] - Recent funding trends indicate a strong interest in injectable fillers and functional skincare materials [11] - Companies are exploring innovative applications of new materials to enhance safety and efficacy in medical beauty products [12] Group 8 - The domestic fragrance brand "Song Dynasty Fragrance" is rapidly expanding, with a unique dual pricing strategy for online and offline sales [13] - The brand's marketing approach, particularly targeting male consumers, has raised concerns about brand positioning and long-term image [13] - The brand's growth is heavily reliant on social media platforms like Douyin for sales [13] Group 9 - The return of popular Douyin beauty influencer Zhu Guagua highlights the ongoing importance of influencer marketing in driving brand growth [14] - Zhu Guagua's success is attributed to a focus on high-quality beauty selections and effective promotional strategies [14] - The trend indicates that brands need to balance collaborations with top influencers and their own direct sales channels for optimal growth [14] Group 10 - Hermès is exploring the skincare market, with plans to launch products post-2028, indicating a strategic move to expand its beauty portfolio [15] - The brand's current beauty offerings primarily include perfumes and cosmetics, with a recent decline in sales prompting a reevaluation of its strategy [15] - This initiative reflects a broader trend of luxury brands diversifying their product lines to enhance market presence [15] Group 11 - Yatsen Group has released China's first beauty innovation white paper, showcasing advancements in research and sustainable development in the beauty sector [16] - The white paper emphasizes the importance of collaboration between academia and industry to drive innovation [16] - Yatsen's investment in R&D highlights its commitment to leading in the global beauty technology landscape [16] Group 12 - The acquisition of Italian hair care brand Foltène by Juhui Group marks a significant step in expanding its portfolio in the hair care market [17] - The brand's focus on gender-specific hair loss products aligns with growing consumer demand in China [17] - This acquisition reflects a trend among domestic beauty companies to pursue multi-brand strategies for international growth [17]

Core Insights - The beauty industry is undergoing a technological transformation, with the integration of medical research driving value upgrades in cosmetics. This dual integration of medicine and beauty is defining a new competitive logic in the industry [3][6][24]. Industry Trends - The 20th China Dermatology Association (CDA) conference showcased over 10,000 dermatologists and more than 100 companies, including both domestic and international beauty brands, highlighting the industry's focus on scientific collaboration [3][4]. - The concept of "medical-research co-creation" emerged as a key theme, with brands actively participating in discussions on how to contribute to the skin science system, moving from mere users of research to active participants in scientific understanding and industry standards [7][24]. Brand Innovations - Winona, a brand known for its scientific foundation, showcased its "NUTE" principle at CDA 2025, which emphasizes clinical needs, unique mechanisms, technology empowerment, and credible evidence in product development [10]. - HBN, a domestic skincare brand, initiated the establishment of a group standard for "Cosmetic Efficacy Evidence Weight Assessment Guidelines," aiming to shift the industry from experience-driven to evidence-based competition [11][13]. - Estee Lauder's Clinique presented a white paper on the causes and distribution patterns of post-inflammatory hyperpigmentation, demonstrating the brand's commitment to scientific validation [14][16]. Research and Development - The integration of research and clinical application is evident in the initiatives taken by brands like Giant Bio and Zhenyan Bio, which are expanding the boundaries of medical-research co-creation through innovative collagen products and clinical studies [20][22]. - The collaboration between brands and medical experts is evolving, with companies like Ximu Yuan conducting extensive research on sensitive skin, showcasing a shift from being mere users of research to contributors to scientific inquiry [24][25]. Future Outlook - The CDA conference highlighted a significant shift in the beauty industry towards a more scientific and collaborative approach, with brands, medical institutions, and research organizations forming a new ecosystem that emphasizes shared data and mutual advancement [47][48]. - The focus on original ingredient research is becoming a core strategy for leading domestic brands, as they aim to differentiate themselves from homogenized competition [38][39].

Investment Rating - The report does not explicitly provide an investment rating for the beauty industry Core Insights - The beauty industry is experiencing a significant shift with domestic brands gaining market share, while international brands like L'Oréal are facing challenges [4][6][10] - The medical beauty sector is expanding, with companies like Juzhi Biotech and Naturals launching innovative products, indicating a trend towards cross-industry collaboration [4][6] - The soap market is evolving with a focus on high-end products and natural ingredients, appealing to environmentally conscious consumers [6] - PDRN technology is transitioning from niche medical applications to mainstream skincare, enhancing product efficacy and market accessibility [6][10] - Hong Kong is emerging as a testing ground for domestic beauty brands aiming for global expansion, leveraging its mature market and tourism recovery [6][10] - The competitive landscape is intensifying, with domestic brands dominating the top rankings and new entrants disrupting traditional market dynamics [4][6][10] Industry Environment - L'Oréal has dropped out of the top 10 rankings in the Douyin beauty market, with domestic brands like Han Shu and Proya leading the charge [4] - The medical beauty market is projected to reach 370 billion by 2025, attracting investments from beauty companies [4] - The soap market is witnessing a shift towards premium products, with handmade soaps gaining traction among consumers [6] - PDRN technology is being adopted in mainstream skincare, with various brands innovating in formulations and applications [6] - Domestic beauty brands are increasingly focusing on international markets, with Hong Kong serving as a strategic entry point [6] Top Brand News - The domestic fragrance brand "Song Dynasty Fragrance" is rapidly expanding, with a unique dual strategy for online and offline sales [12] - Influencer Zhu Guagua has regained prominence in the Douyin beauty market, significantly impacting brand sales through effective marketing strategies [12] - Hermès is exploring the skincare segment, with plans to launch products post-2028, indicating a strategic move to enhance its beauty portfolio [12] - Yatsen Group has released China's first beauty innovation white paper, showcasing advancements in research and sustainable development [12] - Juyi Group has acquired the Italian brand Foltène to strengthen its position in the hair care market, reflecting a trend of consolidation among domestic beauty companies [12]

Core Insights - The Hong Kong stock market's consumer sector experienced fluctuations, with the consumer ETF (513230) showing a slight decline. Notable performers included Samsonite, which surged over 21%, while companies like Wynn Macau and Miniso faced significant declines [1] Group 1: Market Performance - The consumer ETF (513230) tracks the CSI Hong Kong Stock Connect Consumer Theme Index, encompassing major players in the internet e-commerce and new consumption sectors, including Pop Mart, Lao Pu Gold, and Miniso, alongside tech giants like Tencent and Alibaba [2] - During this year's "Double 11" shopping festival, total online retail sales reached nearly 2.4 trillion yuan, marking a new high with a year-on-year growth of over 10% [1] Group 2: Consumer Trends - The "Double 11" event is shifting from a product-driven model to one focused on services, experiences, and emotional value, reflecting changing consumer preferences [1] - The integration of AI technology in e-commerce is becoming increasingly prominent, with platforms aiming to leverage AI to create a "second growth curve" [1]

Group 1 - The Hong Kong stock consumer sector experienced fluctuations, with the consumer ETF (513230) showing a slight decline as of the report time [1] - Notable performers included Samsonite, which surged over 21%, while companies like Wynn Macau and Miniso faced significant declines [1] - The "Double 11" shopping festival saw online retail sales reach nearly 2.4 trillion yuan, marking a new high with a year-on-year growth of over 10% [1] Group 2 - The consumer ETF (513230) tracks the CSI Hong Kong Stock Connect Consumer Theme Index, encompassing a wide range of sectors including new consumption leaders and major internet e-commerce players [2] - The ETF includes companies like Pop Mart, Lao Pu Gold, and major tech firms such as Tencent and Alibaba, highlighting a strong tech-consumer integration [2]

Group 1 - The Hong Kong consumer sector is experiencing slight fluctuations, with the Hong Kong Consumer ETF (513230) down nearly 0.5% as of the report [1] - Notable performers include Samsonite, which surged over 18%, and other companies like Lao Pu Gold and Techtronic Industries, which rose over 2% [1] - The total transaction value for Tmall's Double 11 reached 540.3 billion yuan, showing steady growth compared to last year, while JD's 11.11 sales exceeded 349.1 billion yuan, marking a historical high [1] Group 2 - The recent policies from the Ministry of Finance and the National Bureau of Statistics indicate a focus on boosting consumption, with the CPI rising by 0.2% year-on-year, reversing the previous month's decline [1] - The new tax exemption policy effective from November 1 includes popular categories like mobile phones and sports goods, benefiting related companies in the Hong Kong consumer chain [1] - The digital economy is being emphasized in the "14th Five-Year Plan," promoting the integration of digital and real economies, which is expected to enhance AI applications [2]

Core Insights - The collagen market is experiencing a downturn, with major brands like Kefu Mei and Juzhi Biotech showing a decline in growth and sales performance [1][5][6] - The market is undergoing a transformation, moving from a focus on consumer beauty products to medical applications, as companies adapt to changing consumer demands and competitive pressures [9][12][13] Market Performance - Kefu Mei's GMV on Douyin dropped to 0.5-0.75 billion yuan from over 1 billion yuan year-on-year [5] - Juzhi Biotech's stock price has fallen by 55.18% since reaching a peak of 85.14 HKD on May 20, 2023 [6][7] - The overall sales performance of collagen brands during the 2025 Double Eleven shopping festival was disappointing compared to previous years [5] Strategic Shifts - Juzhi Biotech is expanding into the B2B market by obtaining medical device registration for a collagen-based product, indicating a strategic shift towards medical applications [7][12] - Companies are increasingly focusing on technological advancements and clinical applications rather than just marketing and branding [10][13] Industry Trends - The collagen industry is moving away from purely cosmetic applications towards medical uses, with a focus on proving efficacy through clinical trials and regulatory approvals [9][12][13] - The competitive landscape is evolving, with companies needing to demonstrate the scientific validity of their products to gain market share [12][13] Innovation and Development - Huaxi Biotech is actively pursuing new patents related to collagen, indicating ongoing investment in research and development [10][11] - Companies like Furuida and Mianmei are also advancing in the medical device space, with new certifications and product developments aimed at surgical applications [12][13]

Core Viewpoint - The collagen market is experiencing a downturn, with major brands like 可复美 and 巨子生物 showing significant declines in sales and market presence, indicating a shift from a previously thriving segment to a more cautious phase of industry consolidation and strategic realignment [1][3][4]. Market Performance - The overall performance of the collagen segment during the 2025 Double Eleven shopping festival was disappointing, with notable brands struggling to maintain their previous sales figures [3]. - Data from Citibank indicates that 巨子生物's products faced reduced price attractiveness due to stricter promotional strategies, leading to a decline in sales [4]. - 可复美's GMV on Douyin dropped to between 0.5 and 0.75 billion yuan, down from over 1 billion yuan in the same period last year, reflecting a significant contraction in market demand [4]. - The brand's ranking on Douyin's beauty list fell from the top 10 to the 20th position, highlighting a shift in consumer preferences [4]. Strategic Shifts - Major players like 巨子生物 and 锦波生物 are expanding their business boundaries, moving from consumer markets to B2B opportunities, indicating a strategic pivot in response to market changes [5][6]. - 锦波生物's revenue and net profit growth rates hit a five-year low, with its market capitalization dropping from over 500 billion yuan to 267 billion yuan [5]. - 巨子生物's stock price has seen a decline of 55.18% since reaching a peak in May, reflecting investor concerns over slowing growth and product controversies [5]. Technological Advancements - The collagen market is transitioning from a focus on cosmetic applications to medical uses, with companies investing in R&D to meet regulatory standards for medical devices [7][8]. - 华熙生物 is actively pursuing new patents related to recombinant collagen, indicating a shift towards more scientifically validated products [7][8]. - The competition is now centered around material science and clinical validation, with companies needing to demonstrate the efficacy of their products to gain market share [9]. Industry Dynamics - The narrative surrounding collagen is evolving from a marketing-driven approach to one focused on scientific and clinical validation, with companies needing to establish robust production and quality control systems [9]. - The market is no longer driven by brand recognition alone; the ability to provide clinically proven, stable, and scalable products is becoming the new competitive edge [9].

Core Viewpoint - The collagen market is experiencing a downturn, with major brands like Kefu Mei and Juzhi Biotech showing declining sales and growth rates, indicating a shift from a previously booming market to a more cautious phase [1][3][5]. Market Performance - The overall performance of the collagen sector during the 2025 Double Eleven shopping festival was disappointing, with Kefu Mei's GMV on Douyin dropping to 0.5-0.75 billion yuan, down from over 1 billion yuan in the same period last year [3][4]. - Juzhi Biotech's stock price has fallen by 55.18% since reaching a peak of 85.14 HKD on May 20, 2023, reflecting the company's struggles with slowing growth and ingredient controversies [5][6]. Strategic Shifts - Major players are beginning to cross market boundaries, with Juzhi Biotech expanding into B-end business and Kefu Mei attempting to adapt to changing market dynamics [6][7]. - The market is witnessing a transition from a focus on consumer products to medical applications, as companies aim to leverage technological advancements and regulatory clarity [7][10]. Industry Trends - The industry is moving towards a more scientific and clinical approach, with companies like Huaxi Biotech and Furuida actively pursuing medical device certifications and focusing on the development of injectable collagen products [8][9][10]. - The competitive landscape is shifting from brand recognition and channel dominance to a focus on material science and clinical validation, emphasizing the importance of proving product efficacy [10][11].